We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Vericel Corp
VCEL
$2.39B
| $1.63M | ﹤0.01% |
33,400
+700
| +2% | +$36.2K |
|
1227
Glaukos
GKOS
$8.89B
| $1.62M | ﹤0.01% |
33,700
+300
| +0.9% | +$16.6K |
|
1228
Westamerica Bancorp
WABC
$1.39B
| $1.62M | ﹤0.01% |
28,836
| – | – |
|
1229
Innospec
IOSP
$2.12B
| $1.62M | ﹤0.01% |
19,252
| – | – |
|
1230
Boston Properties
BXP
$11.2B
| $1.62M | ﹤0.01% |
14,956
-5,001
| -25% | -$572K |
|
1231
Carnival Corporation Ltd
CCL
$38.7B
| $1.61M | ﹤0.01% |
64,551
-6,504
| -9% | -$151K |
|
1232
Jacobs Solutions
J
$16.6B
| $1.61M | ﹤0.01% |
14,671
-3,832
| -21% | -$424K |
|
|
CVET
1233
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.61M | ﹤0.01% |
88,600
| – | – |
|
|
WIRE
1234
DELISTED
Encore Wire Corp
WIRE
| $1.59M | ﹤0.01% |
16,767
| – | – |
|
1235
Bio-Rad Laboratories Class A
BIO
$8.86B
| $1.59M | ﹤0.01% |
2,131
-244
| -10% | -$183K |
|
|
HPP
1236
Hudson Pacific Properties
HPP
$765M
| $1.59M | ﹤0.01% |
8,629
| – | – |
|
1237
Amkor Technology
AMKR
$11.3B
| $1.58M | ﹤0.01% |
63,500
| – | – |
|
1238
Lindsay Corp
LNN
$1.17B
| $1.58M | ﹤0.01% |
10,435
| – | – |
|
1239
Prothena Corp
PRTA
$448M
| $1.58M | ﹤0.01% |
22,162
+4,534
| +26% | +$282K |
|
1240
PBF Energy
PBF
$7.22B
| $1.58M | ﹤0.01% |
121,617
+11,600
| +11% | +$120K |
|
1241
Iron Mountain
IRM
$37.4B
| $1.57M | ﹤0.01% |
36,206
-12,788
| -26% | -$576K |
|
1242
Zions Bancorporation
ZION
$10.1B
| $1.57M | ﹤0.01% |
25,439
-12,652
| -33% | -$695K |
|
|
SJI
1243
DELISTED
South Jersey Industries, Inc.
SJI
| $1.57M | ﹤0.01% |
73,989
| – | – |
|
1244
AeroVironment
AVAV
$7.91B
| $1.57M | ﹤0.01% |
18,200
| – | – |
|
1245
Federal Realty Investment Trust
FRT
$10.9B
| $1.57M | ﹤0.01% |
13,294
+155
| +1% | +$18.4K |
|
1246
Ferguson
FERG
$45B
| $1.57M | ﹤0.01% |
11,080
| – | – |
|
|
LAZR
1247
DELISTED
Luminar Technologies
LAZR
| $1.56M | ﹤0.01% |
+6,648
| New | +$1.76M |
|
1248
SITE Centers
SITC
$235M
| $1.56M | ﹤0.01% |
129,200
+17,047
| +15% | +$207K |
|
1249
Pacira BioSciences
PCRX
$1.05B
| $1.55M | ﹤0.01% |
27,600
| – | – |
|
1250
TTM Technologies
TTMI
$11.3B
| $1.54M | ﹤0.01% |
122,720
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.